These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5767879)

  • 21. [Fibrinolysis and its inhibition in gynecology].
    Koutský J; Kraus I; Rybák M; Jirásek JE
    Cas Lek Cesk; 1973 Jan; 112(3):72-5. PubMed ID: 4683823
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of acute fibrinolysis].
    Larrieu MJ
    Sem Ther; 1963 May; 39(5):353-5. PubMed ID: 5877959
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fibrinolysis and its treatment].
    Piguet H
    Sem Ther; 1965; 41(6):352-5. PubMed ID: 5879230
    [No Abstract]   [Full Text] [Related]  

  • 25. The importance of intravascular coagulation and inhibition of the fibrinolytic system in experimental fat embolism.
    Saldeen T
    J Trauma; 1970 Apr; 10(4):287-98. PubMed ID: 5435840
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antifibrinolytic therapy].
    Levi M; ten Cate JW
    Ned Tijdschr Geneeskd; 1995 Mar; 139(12):613-7. PubMed ID: 7700404
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of gynecological bleeding using antifibrinolytic agents].
    Koutský J; Padovec J; Dimitrovová K; Mansfeld V; Kastilová B; Rybák M
    Cesk Gynekol; 1967 Aug; 32(6):429-32. PubMed ID: 5584227
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activation of plasminogen by tissue activators and the inhibitory effects of some anti-plasmin agents].
    Nagamatsu A; Hayashida T; Asakawa T
    Seikagaku; 1968 Aug; 40(8):357-62. PubMed ID: 4236329
    [No Abstract]   [Full Text] [Related]  

  • 29. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 30. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
    Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556
    [No Abstract]   [Full Text] [Related]  

  • 31. Disorders of fibrinolysis.
    Kwaan HC
    Med Clin North Am; 1972 Jan; 56(1):163-76. PubMed ID: 4550188
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of hemostatic preparations in obstetrical hemorrhages].
    Pavlovskiĭ DP; Mikaĭlenko ET
    Pediatr Akus Ginekol; 1976; (1):33-7. PubMed ID: 787905
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fibrinolytic activity of peripheral and uterine blood as influenced by p-aminomethylbenzoic acid (PAMBA) in pgnancy toxemias].
    Sieg U; Flähmig M
    Zentralbl Gynakol; 1969 Dec; 91(51):1662-6. PubMed ID: 5383534
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of uterine hemorrhage with antifibrinolytics].
    Raïchev R; Glavanakova V; Doichinov A; Bobchev T
    Akush Ginekol (Sofiia); 1971; 10(1):38-42. PubMed ID: 5137561
    [No Abstract]   [Full Text] [Related]  

  • 36. [Delivery of healthy twins following a successfully treated premature placental detachment occurring at the end of the 6th month. (Case report)].
    Pleissner K
    Z Arztl Fortbild (Jena); 1968 May; 62(9):477-81. PubMed ID: 5697177
    [No Abstract]   [Full Text] [Related]  

  • 37. Trinitrophenyl-derivative of urinary trypsin inhibitor: a strong antifibrinolytic agent.
    Sumi H; Hamada H; Maehara S; Yoshida E; Tsushima H; Maruyama M; Mihara H
    Acta Haematol; 1987; 78(4):225-8. PubMed ID: 2962413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Observations in 600 endometrial cancers].
    Grube FO; Strobel E
    Arch Gynakol; 1971 Dec; 211(4):558-75. PubMed ID: 5172336
    [No Abstract]   [Full Text] [Related]  

  • 39. [The antifibrinolytic therapy of gynecologic hemorrhages].
    Koutský J; Padovec J; Jirásek JE; Rybák M; Hladovec J; Mansfeld V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):151-65. PubMed ID: 4174653
    [No Abstract]   [Full Text] [Related]  

  • 40. Some properties of the tissue plasminogen activator from the pig heart.
    Hijikata A; Fujimoto K; Kitaguchi H; Okamoto S
    Thromb Res; 1974 Jun; 4(6):731-40. PubMed ID: 4844057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.